Lantheus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lantheus and other ETFs, options, and stocks.

About LNTH

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. 

CEO
Brian A. Markison
CEOBrian A. Markison
Employees
808
Employees808
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
1956
Founded1956
Employees
808
Employees808

LNTH Key Statistics

Market cap
4.42B
Market cap4.42B
Price-Earnings ratio
28.02
Price-Earnings ratio28.02
Dividend yield
Dividend yield
Average volume
1.31M
Average volume1.31M
High today
$66.88
High today$66.88
Low today
$66.20
Low today$66.20
Open price
$66.57
Open price$66.57
Volume
339.35K
Volume339.35K
52 Week high
$111.29
52 Week high$111.29
52 Week low
$47.25
52 Week low$47.25

Stock Snapshot

The current Lantheus(LNTH) stock price is $66.71, with a market capitalization of 4.42B. The stock trades at a price-to-earnings (P/E) ratio of 28.02.

During the trading session on 2025-12-28, Lantheus(LNTH) shares reached a daily high of $66.88 and a low of $66.20. At a current price of $66.71, the stock is +0.8% higher than the low and still -0.3% under the high.

Trading volume for Lantheus(LNTH) stock has reached 339.35K, versus its average volume of 1.31M.

Over the past 52 weeks, Lantheus(LNTH) stock has traded between a high of $111.29 and a low of $47.25.

Over the past 52 weeks, Lantheus(LNTH) stock has traded between a high of $111.29 and a low of $47.25.

LNTH News

The Motley Fool 4d
Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year

The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case. New York City-bas...

Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year
The Motley Fool 4d
This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year

After a bruising year for the stock, one fund leaned further into a business throwing off real cash and quietly reshaping its growth engine. New York City-base...

This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year
Simply Wall St 6d
Reassessing Lantheus Holdings After a 27.6% Slide and Recent Share Price Rebound

Wondering if Lantheus Holdings is quietly turning into a bargain, or if the market already sees something you do not? Let us break down what the recent numbers...

Reassessing Lantheus Holdings After a 27.6% Slide and Recent Share Price Rebound

Analyst ratings

85%

of 13 ratings
Buy
84.6%
Hold
15.4%
Sell
0%

People also own

Based on the portfolios of people who own LNTH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.